Powered by: Motilal Oswal
2026-08-25 10:07:43 am | Source: Geojit Financial Services Ltd
Buy LT Foods Ltd For Target Rs.514 By Geojit Financial Services Ltd
Buy LT Foods Ltd For Target Rs.514 By Geojit Financial Services Ltd

LT Foods Ltd. (LTF) is a global consumer-focused specialty food company specializing in basmati rice, organic foods and ready to eat/cook (RTE/RTC) products. Its flagship brands include Daawat in India and Royal in North America. The company has a presence in more than 80 countries with significant regional exposure in the US, Europe, etc.

* Revenue grew 28% YoY (19% YoY excluding Golden Star) and 8% QoQ, reflecting broad -based strength across geographies.

* The core Basmati and specialty rice segment (89% of revenue) grew 34% YoY on 11% volume growth, while Organic Foods & Ingredients declined 13% YoY amid business restructuring and RTH/RTC products grew 13% YoY.

* Gross margin declined 210bps YoY to 32.6% due to changes in shipment terms, while EBITDA rose 20% YoY with a modest 60bps margin contraction to 11.5%. PAT grew 9% YoY.

* India business grew 23% in value and 12% in volume, with market share rising to 23.1%, supported by premiumisation and increasing household penetration.

* North America grew 49% YoY (normalised 27%), with Royal holding over a 60% share and Golden Star retaining its No.1 Jasmine rice position; a new 156,000 sq ft Texas warehouse (completion Jan '27) will expand distribution.

* Margin expansion is expected as value-added segments gain scale, with the RTE/RTC business targeted to achieve breakeven (Rs.400cr) by FY27-end and Organic EBITDA projected to recover to Rs.70-80cr.

Outlook & Valuation

The core basmati franchise continues to deliver strong volume-led growth, while market share gains in India reinforce the premiumisation thesis. Near-term margins face two transitory drags: the organic segment’s shift from a wholesale model to a direct CPG (Consumer Packaged Goods) model and changes in related-party shipment terms. Regional expansion in North America, the UK/Europe investment phase and launches in the Middle East support the medium-term volume outlook, while the business has navigated tariff resets and geopolitical volatility without material impact. Branded, premium, and RTE/RTC products are expected to remain key growth drivers, delivering stronger growth than the broader portfolio. We value the stock at 17x on FY28 EPS (3-yr avg. 20x) to arrive at a target price of Rs. 514 and maintain our BUY rating.

Key Highlights

* India's share climbed to 23.1% on the back of premiumisation, wider distribution and rising penetration. In the US, Royal stayed above a 60% share, and Golden Star kept its lead in Jasmine rice.

* Freight rates surged from $200 to $4,000 due to regional shipping challenges in the Middle East, placing significant pressure on margins across Europe, the U.K., and Middle Eastern markets.

* The RTH/RTC segment is positioned for strong growth, with a new U.S. facility expected to support a doubling of the ready-to-eat business within three years, while the broader category targets 15-20% annual growth and breakeven at Rs.400cr revenue.

* Inventory days eased to 187 from 221 YoY, helping cut the overall working-capital cycle to 170 days from 195.

* U.S. tariff fluctuations led to pricing volatility; however, the tariff reduction from 50% to 10% helped improve gross margins.

* Nature Bio Foods is transitioning its organic segment to CPG model and investing in Europe, with EBITDA margins expected to improve from ~4% to 7-8% by FY27 end and reach double digits thereafter.

* Paddy costs remain elevated; however, with most acreage irrigated and a year’s inventory already secured, management sees limited sourcing risk and expects to pass on any crop-driven inflation.

 

For More Geojit Financial Services Ltd Disclaimer https://www.geojit.com/disclaimer
SEBI Registration Number: INH200000345

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here